RxDoctor Payments Data

Phillip Barnes

Physician Assistant · Hoisington, KSNPI 1538392691

Payments from drug & device makers

$3,666in general payments, 2019–2025

Across 243 payments — averaging $15.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$850
  • AstraZeneca$577
  • Amgen$396
  • Lilly USA, LLC$365
  • GSK$170
  • Novo Nordisk$144
  • plus $1K from 29 others

What the payments were for

  • Food & beverage$3,666100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,666 in reported general payments places this provider in the 85th percentile of 1,016 physician assistant providers in Kansas.

See all physician assistant providers in Kansas

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tresiba Flextouch U-200Insulin Degludec57$82,527
OzempicSemaglutide55$62,985
Fiasp FlextouchInsulin Aspart (Niacinamide)39$54,089
JardianceEmpagliflozin57$51,785
RybelsusSemaglutide37$51,064
EliquisApixaban52$38,182
TrulicityDulaglutide40$37,849
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog29$35,523
FarxigaDapagliflozin Propanediol36$23,994
MyrbetriqMirabegron32$19,778
Trelegy ElliptaFluticasone/Umeclidin/Vilanter27$18,151
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog17$17,631
XareltoRivaroxaban27$15,215
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr17$12,580
Repatha SureclickEvolocumab12$10,851

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$144$114,04992 claims
Boehringer IngelheimJardiance, Stiolto Respimat$57$57,38869 claims
PfizerEliquis$108$38,18252 claims
Lilly USA, LLCTrulicity$365$37,84940 claims
GSKTrelegy Ellipta, Anoro Ellipta, Arnuity Ellipta$170$33,94355 claims
AstraZenecaFarxiga$577$23,99436 claims
Johnson & JohnsonXarelto$75$15,21527 claims
MerckJanuvia$12$7,56312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,016 physician assistant providers in Kansas.

Other physician assistant in Hoisington

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →